Stephen Hoffman
2017 - Aadi Bioscience
In 2017, Stephen Hoffman earned a total compensation of $2.1M as Chief Executive Officer at Aadi Bioscience.
Compensation breakdown
| Non-Equity Incentive Plan | $21,542 |
|---|---|
| Option Awards | $2,007,300 |
| Salary | $39,167 |
| Other | $89 |
| Total | $2,068,098 |
Hoffman received $2M in option awards, accounting for 97% of the total pay in 2017.
Hoffman also received $21.5K in non-equity incentive plan, $39.2K in salary and $89 in other compensation.
Rankings
In 2017, Stephen Hoffman's compensation ranked 5,333rd out of 14,666 executives tracked by ExecPay. In other words, Hoffman earned more than 63.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,333 out of 14,666 | 64th |
Division Manufacturing | 1,910 out of 5,772 | 67th |
Major group Chemicals And Allied Products | 569 out of 2,075 | 73rd |
Industry group Drugs | 439 out of 1,731 | 75th |
Industry Pharmaceutical Preparations | 346 out of 1,333 | 74th |
Source: SEC filing on May 15, 2018.
Hoffman's colleagues
We found three more compensation records of executives who worked with Stephen Hoffman at Aadi Bioscience in 2017.
News
BODY & MIND CEO Michael Mills' 2022 pay slips 4% to $403K
February 10, 2023
BODY & MIND COO Stephen Hoffman's 2021 pay rises 2% to $462K
February 11, 2022
BODY & MIND COO Stephen Hoffman's 2020 pay jumps 106% to $451K
December 31, 2020
Aadi Bioscience CEO Stephen Hoffman's 2019 pay jumps 45% to $2.1M
April 27, 2020
BODY & MIND Director, and President of NMG Robert Hasman's 2019 pay rises 18% to $441K
December 10, 2019
Aadi Bioscience CEO Stephen Hoffman's 2018 pay falls 30% to $1.4M
April 30, 2019